We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 188

Australian court finds human gene mutation to be patentable

  • Shook Hardy & Bacon LLP
  • -
  • Australia, USA
  • -
  • September 11 2014

A full panel of the Federal Court of Australia has upheld its earlier ruling that an isolated but naturally occurring nucleic acid, BRCA1, can be

Federal Circuit addresses personal jurisdiction in patent infringement litigation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 30 2012

Finding that the U.S. Supreme Court “has yet to reach a consensus on the proper articulation of the stream-of-commerce theory” of personal jurisdiction to assess whether a court has jurisdiction over a non-resident defendant in a patent infringement suit, the Federal Circuit Court of Appeals has applied its own theory, which assesses the pleadings and evidence under “any articulation of the stream-of-commerce theory,” and has determined that a district court in Wyoming properly dismissed two patent infringement lawsuits for lack of jurisdiction

Court orders dispute over 23andMe DNA test kits to arbitration

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

A multidistrict litigation court in California has ordered false-advertising, class-action claims filed against personal genetics company 23andMe to

Company seeks SCOTUS order allowing Federal Circuit to apply Alice standard

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 21 2014

Advanced Biological Laboratories SA (ABL) has requested in a reply brief that the U.S. Supreme Court (SCOTUS) issue a GVR ordergrant its

French company prevails in dispute with FDA over drug-classification ruling

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 3 2012

A federal court in the District of Columbia has determined that the Food and Drug Administration (FDA) erred when it classified a combination drug-device product as primarily a drug, thus subjecting its French manufacturer to more burdensome regulatory requirements

Supplier sentenced for illegal sales of non-approved drugs

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 26 2014

According to the U.S. Department of Justice, a federal court in Virginia has sentenced a U.S. citizen, who owned and operated several companies in

Federal court addresses spoliation issues on remand in Hynix v. Rambus

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 3 2012

On remand from the Federal Circuit Court of Appeals, a federal district court in California has reversed its determination that Rambus, Inc. did not spoliate evidence by shredding hundreds of boxes in the months preceding its implementation of a strategy to aggressively protect its technology patents

Court denies Myriad’s request to enjoin sale of rival BRCA1BRCA2 tests

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 20 2014

A federal court in Utah has denied the request for a preliminary injunc- tion filed by Myriad Genetics against a rival company that offered tests

Vaccine developer agrees to settle shareholder litigation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

A putative class action instituted by three shareholders against the nowbankrupt biotechnology company Biovest International, Inc., alleging

Class action filed against 23andMe, Inc. over efficacy of home DNA test kits

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 30 2014

A New Mexico resident has filed a putative nationwide class action against 23andMe, Inc., alleging that claims for its DNA Collection Kits&mdash